E2F-dependent induction of p14ARF during cell cycle re-entry in human T cells
Related Experiment Video
Updated: Jul 11, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Ana Gutierrez del Arroyo1, Selma El Messaoudi, Paula A Clark
1Cancer Research UK, London Research Institute, Lincoln's Inn Fields, London, UK.
Abstract:
The ARF protein, encoded by alternate exon usage within the CDKN2A locus, provides a link between the retinoblastoma (pRb) and p53 tumor suppressor pathways. Agents that disable pRb or otherwise impinge on the E2F family of transcription factors induce expression of ARF, resulting in stabilization of p53 and activation of p53-regulated genes. However, in some cell types ARF is not induced upon cell cycle re-entry, as expected of a conventional E2F target gene, leading to the suggestion that the ARF promoter only responds to supra-physiological or aberrant levels of E2F. These properties have recently been attributed to a variant E2F binding site but attempts to map specific response elements within the ARF promoter have generally yielded confusing answers. Here we show that in IL2-dependent T-lymphocytes, ARF expression is induced as cells progress from G(0) into S phase, in parallel with other bona fide E2F target genes. This is accompanied by increased association of E2F1 with the endogenous ARF promoter. Our findings suggest that the ability of ARF to register normal proliferative cues depends on the levels of E2F generated in different settings and argue against the idea that it reacts exclusively to oncogenic signals.
Insights
The ARF protein links the pRb and p53 tumor suppressor pathways. In T-lymphocytes, ARF expression responds to normal cell cycle progression, not just aberrant signals, depending on E2F levels.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Tumor Suppressor Pathways
Background:
- The ARF protein, encoded by the CDKN2A locus, acts as a crucial link between the retinoblastoma (pRb) and p53 tumor suppressor pathways.
- ARF expression is typically induced by agents that disrupt pRb or affect E2F transcription factors, leading to p53 stabilization and activation.
- Previous studies suggested ARF's promoter might only respond to abnormally high E2F levels, as it's not always induced during normal cell cycle re-entry.
Purpose of the Study:
- To investigate the regulation of ARF expression in response to normal proliferative cues.
- To determine if ARF acts as a conventional E2F target gene in specific cell types.
- To clarify the role of E2F levels in ARF promoter activation.
Main Methods:
- Analyzing ARF expression during cell cycle progression in IL2-dependent T-lymphocytes.
- Assessing the association of E2F1 with the endogenous ARF promoter.
- Comparing ARF induction patterns with other known E2F target genes.
Main Results:
- ARF expression is induced in IL2-dependent T-lymphocytes as they transition from G(0) to S phase.
- This induction occurs in parallel with other established E2F target genes.
- Increased binding of E2F1 to the ARF promoter was observed during normal cell cycle progression.
Conclusions:
- ARF expression can be regulated by physiological levels of E2F generated during normal cell proliferation.
- The response of the ARF promoter to E2F is context-dependent, varying with E2F levels.
- These findings challenge the notion that ARF exclusively responds to oncogenic signals and highlight its role in registering normal proliferative cues.
Related Concept Videos
Mitogens and the Cell Cycle
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Inhibition of Cdk Activity
Replicative Cell Senescence

